The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
74148803 7414880 3 F 20100416 20160823 20100609 20160915 EXP US-ROCHE-708118 ROCHE 67.00 YR F Y 72.80000 KG 20160916 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
74148803 7414880 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) FREQUENCY : OVER 30-90 MIN ON DAYS 1 AND 15, ON 30 APRIL 2010, PATIENT REMOVED FROM STUDY.?COURSE 1 Y 125085 10 MG/KG
74148803 7414880 2 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) COURSE 2 Y 125085 1430 MG
74148803 7414880 3 SS TEMSIROLIMUS TEMSIROLIMUS 1 Intravenous (not otherwise specified) FREQUENCY : ON DAYS 1,8,15,22 Y 0 25 MG
74148803 7414880 4 SS TEMSIROLIMUS TEMSIROLIMUS 1 Intravenous (not otherwise specified) DOSE REDUCED. ON 30 APRIL 2010, PATIENT REMOVED FROM STUDY. 0 20 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
74148803 7414880 1 Carcinoid tumour
74148803 7414880 3 Carcinoid tumour

Outcome of event

Event ID CASEID OUTC COD
74148803 7414880 OT
74148803 7414880 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
74148803 7414880 Anal abscess
74148803 7414880 Anxiety
74148803 7414880 Atrial fibrillation
74148803 7414880 Epistaxis
74148803 7414880 Hypophosphataemia
74148803 7414880 Pulmonary haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found